Gutiérrez-Corrales A,
Campano-Cuevas E, Castillo-Dalí G, Torres-Lagares D, Gutiérrez-Pérez JL. Ability of salivary biomarkers
in the prognostic of systemic and buccal inflammation. J Clin Exp Dent. 2017;9(5):e716-22.
doi:10.4317/jced.53776
References
|
1. Demetriou
N, Drikos G, Bambionitakis
A. Relation between gingival fluid and mixed and parotid salivary IgA. J Periodontol. 1978;49:64-6. |
|
|
|
|
|
2. Malon
RS, Sadir S, Balakrishnan
M, Córcoles EP. Saliva-based biosensors:
noninvasive monitoring tool for clinical diagnostics. Biomed Res Int. 2014;2014:962903. |
|
|
|
|
|
3. Lamby
CP, Gomez OL, Jaramillo L. Salivary a -Amylase : Relation with Dental
Caries and Health in General. Univ Odontol. 2013;32:93-101. |
|
|
|
|
|
4. Sadi
H, Finkelman M, Rosenberg M. Salivary cortisol, salivary alpha amylase, and the dental anxiety
scale. Anesth Prog. 2013;60:46-53. |
|
|
|
|
|
5. Spielmann
N, Wong DT. Saliva: Diagnostics and therapeutic perspectives. Oral Dis. 2011;17:345-54. |
|
|
|
|
|
6.
Castro CE, Koss MA, López ME. Biochemical markers of the periodontal ligament. Med
Oral. 2003;8:322-8. |
|
|
|
|
|
7. Miller CS, King CP, Langub MC, Kryscio RJ, Thomas
MV. Salivary biomarkers of existing periodontal disease: a cross-sectional
study. J Am Dent Assoc. 2006;137:322-9. |
|
|
|
|
|
8. Salvi
GE, Franco LM, Braun TM, Lee A, Rutger Persson G, Lang NP, Giannobile
WV. Pro-inflammatory biomarkers during experimental gingivitis in patients
with type 1 diabetes mellitus: A proof-of-concept study. J Clin Periodontol. 2010;37:9-16. |
|
|
|
|
|
9. Tsai CC, Ku CH, Ho YP,
Ho KY, Wu YM, Hung CC. Changes in gingival crevicular
fluid interleukin-4 and interferon-gamma in patients with chronic periodontitis before and after periodontal initial
therapy. Kaohsiung J Med Sci. 2007;23:1-7. PMid:17282979 |
|
|
|
|
|
10.
Garrido Flores M, Ordenes Vitali T, Segú Cabrera C,
Baeza Paredes M, García-Sesnich J, Hernandez Rios M. Asociación
entre niveles de TNF-alpha en fluido crevicular gingival de dientes con periodontitis apical
asintomática. Rev Clín Periodoncia Implantol Rehabil Oral. 2011;4:130-3. |
|
|
|
|
|
11.
Dutzan N, Vernal R, Hernandez
M, Dezerega A, Rivera O, Silva N, et al. Levels of interferon-gamma and transcription factor
T-bet in progressive periodontal lesions in patients with chronic periodontitis. J Periodontol.
2009;80:290-6. |
|
|
|
|
|
12.
Arroyo-Morales M, Olea N, Ruíz C, del Castilo J de
D, Martinez M, Lorenzo C, et al. Massage after exercise--responses of immunologic and
endocrine markers: a randomized single-blind placebo-controlled study. J
Strength Cond Res. 2009;23:638-44. |
|
|
|
|
|
13. Ben-Aryeh H, Naon H, Szargel R, Horowitz G, Gutman
D. The concentration of salivary IgA in whole and
parotid saliva and the effect of stimulation. Int J
Oral Maxillofac Surg;
1986;15:81-4. PMid:3083009 |
|
|
|
|
|
14. Favre L, Spertini F, Corthésy B. Secretory IgA possesses
intrinsic modulatory properties stimulating mucosal
and systemic immune responses. J Immunol.
2005;175:2793-800. |
|
|
|
|
|
15. Gross A, Setterstrom JA, D'Alessandro SM, Van
Swol RL. Immunoglobulins
in periodontal tissues. I. Concentrations of immunoglobulins
in normal and inflamed gingiva. J Periodontol. 1979;50:581-5. |
|
|
|
|
|
16.
Güven O, De Visscher JG. Salivary IgA in periodontal disease. J Periodontol. 1982;53:334-5. |
|
|
|
|
|
17. Kugler
J, Hess M, Haake D. Secretion of salivary
immunoglobulin A in relation to age, saliva flow, mood states, secretion of
albumin, cortisol, and catecholamines
in saliva. J
Clin Immunol. 1992;12:45-9. |
|
|
|
|
|
18. Baik
JE, Hong SW, Choi S, Jeon
JH, Park OJ, Cho K, Seo DG, Kum
KY, Yun CH, Han SH.
Alpha-amylase is a human salivary protein with affinity to lipopolysaccharide of Aggregatibacter
actinomycetemcomitans. Mol Oral Microbiol. 2013;28:142-53. |
|
|
|
|
|
19. Fábián
TK, Hermann P, Beck A, Fejérdy P, Fabián G. Salivary defense proteins: Their network and
role in innate and acquired oral immunity. Int J
Mol Sci. 2012;13:4295-320. |
|
|
|
|
|
20. Filaire
E, Dreux B, Massart A, Nourrit B, Rama LM, Teixeira A. Salivary alpha-amylase, cortisol and chromogranin A
responses to a lecture: Impact of sex. Eur J Appl Physiol. 2009;106:71-7. |
|
|
|
|
|
21. Henderson AT, Fisher
JF, Blair J, Shea C, Li TS, Bridges KG. Effects of rib raising
on the autonomic nervous system: a pilot study using noninvasive biomarkers. J Am Osteopath Assoc. 2010;110:324-30. |
|
|
|
|
|
22. Scannapieco
F, Torres G, Levine MJ. Salivary alpha-amylase: role in dental plaque and
caries formation. Crit Rev Oral Biol Med. 1993; 4:301–7. |
|
|
|
|
|
23. Pavitra
Vibhakar A, Sangeeta Patankar R, Monica Yadav R, Parag Vibbhakar A. Salivary
Total Protein Levels and their correlation to Dental Caries. Int J Oral Maxillofac Pathol. 2013;4:13-6. |
|
|
|
|
|
24. Nagler
R, Lischinsky S, Diamond E, Drigues
N, Klein I, Reznick AZ.
Effect of cigarette smoke on salivary proteins and enzyme activities. Arch Biochem Biophys. 2000;379:229-36. |
|
|
|
|
|
25. Rai
B, Kharb S, Jain R, Anand
SC. Biomarkers of periodontitis in oral fluids. J Oral Sci. 2008;50:53-6. |
|
|
|
|
|
26.
Liu J, Duan Y. Saliva: a potential media for disease diagnostics and monitoring. Oral Oncol. 2012;48:569-77. |
|
|
|
|
|
27. Spielmann
N, Wong DT. Saliva: diagnostics and therapeutic perspectives. Oral Dis. 2011;17:345-54. |
|
|
|
|
|
28.
Torres-Lagares D, Recio-Lora C, Castillo-Dali G,
Ruiz-de-Leon-Hernandez G,
Hita-Iglesias P, Serrera-Figallo MA, et al. Influence of state anxiety and trate
anxiety in postoperative in oral surgery. Med Oral Patol
Oral y Cir Bucal. 2014;19:e403–8. |
|
|
|
|
|
29. Trueba
AF, Mizrachi D, Auchus
RJ, Vogel PD, Ritz T. Effects of psychosocial stress on the pattern of
salivary protein release. Physiol Behav. 2012;105:841-9. |
|
|
|
|
|
30. Boyle JO, Mao L,
Brennan JA, Koch WM, Eisele DW, Saunders JR, Sidransky D. Gene mutations in saliva as molecular
markers for head and neck squamous cell carcinomas.
Amer J Surg. 1994;168:429-32. PMid:7977967 |
|
|
|
|
|
31. Zhang L, Farrell JJ,
Zhou H, Elashoff D, Akin D, Park NH, Chia D, Wong DT. Salivary transcriptomic
biomarkers for detection of resectable pancreatic
cancer. Gastroenterology 2010;138:949-57. |
|
|
|
|
|
32. Rao
PV, Reddy AP, Lu X, Dasari S, Krishnaprasad
A, Biggs E, Roberts CT, Nagalia SR. Proteomic
identification of salivary biomarkers of type-2 diabetes. J Proteome Res 2009;8:239-45. |
|
|
|
|
|
33. Malamud D. Oral
diagnostic testing for detecting human immunodeficiency virus-1 antibodies: a
technology whose time has come. Am J Med.
1997;102:9-14. PMid:9217633 |
|
|
|
|
|
34. Kountoruras
J. Detecting Helicobater pylori. Diagnostic tests
for Helicobacter pylori. Gut. 1998;42:900-1. PMid:9691937
PMCid:PMC1727133 |
|
|
|
|
|
35. Nicholas BL, Skipp P, Barton S, Singh D, Bagmane
D, Mould R, et al. Identification of lipocalin and apolipoprotein A1 as biomarkers of chronic obstructive
pulmonary disease. Am J Respir
Crit Care Med 2010; 181:1049–60. |
|
|
|
|
|
36. Zheng
H, Li R, Zhang J, Zhou S, Ma Q, Zhou Y, et al. Salivary biomarkers indicate
obstructive sleep apnea patients with cardiovascular diseases. Sci Rep. 2014;4:7046. |
|
|
|
|
|
37. Schrepf
A, Thaker PH, Goodheart
MJ, Bender D, Slavich GM, Dahmoush
L, et al. Diurnal cortisol and survival in
epithelial ovarian cancer. Psychoneuroendocrinology.
2015;53:256-67. |
|
|
|
|
|
38. Chang YT, Wu CC, Shyr YM, Chen TC, Hwang TL, Yeh
TS, et al. Secretome-based identification of ULBP2
as a novel serum marker for pancreatic cancer detection. PLoS
One. 2011;6:e20029. |
|
|
|
|
|
39. Vocka
M, Langer D, Petrtyl J, Vockova
P, Hanus T, Kalousova M, et
al. Trefoil factor family (TFF) proteins as potential serum biomarkers in
patients with metastatic colorectal cancer. Neoplasma. 2015;62:470-7. |
|
|
|
|
|
40. Stiekema
A, Boldingh QJ, Korse CM,
van der Noort V, Boot H,
van Driel WJ, et al. Serum human epididymal protein 4 (HE4) as biomarker for the
differentiation between epithelial ovarian cancer and ovarian metastases of
gastrointestinal origin. Gynecol Oncol. 2015;136:562-6. |
|
|
|
|
|
41.
Shiiki N, Tokuyama S,
Sato C, Kondo Y, Saruta J, Mori
Y, et al. Biomarkers. Association between saliva PSA and serum
PSA in conditions with prostate adenocarcinoma. Biomarkers. 2011;16:498-503. |
|
|
|
|
|
42. Streckfus
CF, Mayorga-Wark O, Arreola
D, Edwards C, Bigler L, Dubinsky WP. Breast cancer
related proteins are present in saliva and are modulated secondary to ductal carcinoma in situ of the breast. Cancer Invest. 2008;26:159-67. |
|
|
|
|
|
43. Turk MJ, Wolchok JD, Guevara-Patino JA,
Goldberg SM, Houghton AN. Multiple pathways to tumor immunity and concomitant
autoimmunity. Immunol Rev. 2002;188:122-35. |
|
|
|
|
|
44. Warnakulasuriya
S, Soussi T, Maher R, Johnson N, Tavassoli M. Expression of p53
in oral squamous cell carcinoma is associated with
the presence of IgG and IgA
p53 autoantibodies in sera and saliva of the
patients. J Pathol. 2000;192:52-7. PMid:10951400 |
|
|
|
|
|
45. Soussi
T. P53 Antibodies in the sera of patients with various types of cancer: a
review. Cancer Res. 2000;60:1777-88. |
|
|
|
|
|
46. Buduneli
E, Mantyla P, Emingil G, Tervahartiala T, Pussinen P, Barış N, Akıllı
A, Atilla G, Sorsa T.
Acute myocardial infarction is reflected in salivary matrix
metalloproteinase-8 activation level. J Periodontol.
2011;82:716-25. |
|
|
|
|
|
47. Mirzaii-Dizgah
I, Jafari-Sabet M. Unstimulated
whole saliva creatine phosphokinase
in acute myocardial infarction. Oral Dis.
2011;17:597-600. |
|
|
|
|
|
48. Mirzaii-Dizgah
I, Riahi E. Salivary troponin
I as an indicator of myocardial infarction. Indian J Med Res. 2013;138:861-5. |
|
|
|
|
|
49. Diercks
DB, Kirk JD, Lindsell CJ, Pollack CV Jr, Hoekstra JW, Gibler WB, et
al. Door-to-ECG time in patients with chest pain presenting to the ED. Am J Emerg Med. 2006;24:1-7. |
|
|
|
|
|
50. Xiao H, Wong DT.
Proteomics and its applications for biomarker discovery in human saliva. Bioinformation 2011;5:294-6. |
|
|
|
|
|
51. Hu
S, Xie Y, Ramachandran P,
Ogorzalek Loo RR, Li Y, Loo JAet al. Large-scale
identification of proteins in human salivary proteome by liquid
chromatography/ mass spectrometry and two-dimensional gel
electrophoresis-mass spectrometry. Proteomics. 2005;5:1714-28. |
|
|
|
|
|
52.
Sabatine MS, Morrow DA,
de Lemos JA, Gibson CM, Murphy SA, Rifai N, et al. Multimarker approach to risk stratification in non-ST elevation acute coronary
syndromes: simultaneous assessment of troponin I,
C-reactive protein, and B-type natriuretic peptide.
Circulation. 2002;105:1760-3. |
|
|
|
|
|
53. Miller CS, Foley JD
3rd, Floriano PN, Christodoulides
N, Ebersole JL, Campbell CL, et al. Utility of
salivary biomarkers for demonstrating acute myocardial infarction. J Dent
Res. 2014;93:72S-79S. |
|
|
|
|
|
54. Mahmood
AA, Ibrahim LM. Effects of the examination stress on periodontal health
status and salivary IL-1b among Iraqi dental students. J Baghdad Coll Dent. 2013;24:72-8. |
|
|
|
|
|
55. Usui
T, Yoshikawa T, Ueda SY, Katsura Y, Orita K, Fujimoto S. Effects of acute prolonged strenuous
exercise on the salivary stress markers and inflammatory cytokines. Jpn J Phys Fitness Sports Med. 2011;60:295-304. |
|
|
|
|
|
56.
Filaire E, Larue J,
Portier H, Abed A, Graziella
PD, Teixeira A, et al. Lecturing to
200 students and its effects on cytokine concentration and salivary markers
of adrenal activation. Stress
Health. 2011;27:e25-35. |
|
|
|
|
|
57. Tsujita
S, Morimoto K. Secretory IgA
in saliva can be a useful stress marker. Environ Health Prev
Med. 1999;4:1-8. |
|
|
|
|
|
58. Brandtzaeg
P. Human secretory immunoglobulins.
3. Immunochemical and physicochemical studies of secretory
IgA and free secretory
piece. Acta
Pathol Microbiol Scand B Microbiol Immunol. 1971;79:165-88. |
|
|
|
|
|
59. Brandtzaeg
P. Secretory immunity with special reference to the
oral cavity. J Oral
Microbiol. 2013;5. Epub 2013 Mar 11. PMid:23487566
PMCid:PMC3595421 |
|
|
|
|
|
60. Demetriou
N, Drikos G, Bambionitakis
A. Relation between Gingival Fluid and Mixed and Parotid Salivary IgA. J Periodontol. 1978;49:64-6. |
|
|
|
|
|
61. Ben-Aryeh H, Naon H, Szargel R, Horowitz G, Gutman
D. The concentration of salivary IgA in whole and
parotid saliva and the effect of stimulation. Int J
Oral Maxillofac Surg. 1986;1:81-4. PMid:3083009 |
|
|
|
|
|
62. Brandtzaeg
P. Human Secretory Inmunoglobulins-VII
of Parotid IgA and Other Secretory
Proteins in Relation to the Rate of Flow and Duration of Secretory
Stimulus. Arch Oral Biol.
1971;16:1295-310. PMid:5003643 |
|
|
|
|
|
63. Fábián
TK, Hermann P, Beck A, Fejérdy P, Fábián G. Salivary defense proteins: their network and role
in innate and acquired oral immunity. Int J Mol
Sci. 2012;13:4295-320. |
|
|
|
|
|
64. Kim KD, Zhao J, Auh S, Yang X, Du P, Tang H, et al. Adaptive immune cells
temper initial innate responses. Nat Med. 2007;13:1248-52. |
|
|
|
|
|
65. Nater
UM, Rohleder N. Salivary alpha-amylase as a
non-invasive biomarker for the sympathetic nervous system: current state of
research. Psychoneuroendocrinology. 2009;34:486-96. |
|
|
|
|
|
66.
de Santana-Santos T, de Souza-Santos AA, Martins- Filho PR, da Silva LC, de Oliveira
E, Silva ED, et al. Prediction of
postoperative facial swelling, pain and trismus
following third molar surgery based on preoperative variables. Med Oral Patol
Oral Cir Bucal. 2013;18:65-70. |
|
|
|
|
|
67. Laskin
DM, Abubaker AO, Strauss RA. Accuracy of predicting
the duration of a surgical operation. J Oral Maxillofac
Surg. 2013;71:446-7. |
|
|
|
|
|
68. Bello S, Adeyemo W, Bamgbose BO, Obi EV,
Adeyinka A. Effect of age, impaction types and
operative time on inflammatory tissue reactions following lower third molar
surgery. Head Face Med. 2011;7:8. https://doi.org/10.1186/1746-160X-7-8 PMid:21527036 PMCid:PMC3114767 |
|
|
|
|
|
69. Holland CS. The
influence of methylprednisolone on postoperative
swelling following oral surgery. Br J Oral and Maxillofac
Surg. 1987;25:293-9. PMid:3304412 |
|
|
|
|
|
70.
Puche F, Martínez Gonzalez JM, Blanco L, Gómez Font
R, Donado M. Estudio de los efectos del diclofenaco
sódico en el control de la inflamación y trismo postoperatorio del tercer
molar inferior. Av Odontoestomatol.
1995;11:225-33. |
|
|
|
|
|
71. Seymour R, Meechan JG, Blair GS. An investigation into
post-operative pain after third molar surgery under local analgesia. Br J Oral Maxillofac Surg. 1985;23:410-8. PMid:2933061 |
|
|
|
|
|
72. Meechan
R, Seymour A. The use of third molar surgery in clinical pharmacology. Br J Oral Maxillofacial Surg. 1993;31:360-5. PMid:8286289 |
|
|
|
|
|
73.
Capuzzi P, Montebugnoli
L, Vaccaro MA. Extraction of impacted third molars. A longitudinal prospective study
on factors that affect postoperative recovery. Oral Surg
Oral Med Oral Pathol. 1994;77:341-3. PMid:8015796 |
|
|
|
|||||||||||||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|